The number was expected to increase further as the details were being uploaded to the CoWin portal till late evening.
The fraudsters convince the people that they need to schedule a date for the booster dose, and ask them to share the OTP sent on their mobile for confirmation.
In August this year, the DCGI had approved a proposal by the CMC, Vellore to study the mixing of Covid vaccines Covaxin and Covishield in 300 volunteers but its results are yet to come out.
According to the government, approximately 33 lakh vaccines are currently available in the State and they do not foresee any kind of shortage.
Though the government document did not clarify on the type of vaccine to be available as the third dose for beneficiaries, officials said that it will be the same vaccine as the two doses before.
Research shows crossover vaccines are more effective, but no local supportive data; State awaiting directions from the Centre
Sources in the National Technical Advisory Group on Immunisation said the panel is meeting this week to deliberate on additional shots of Covid-19
British Prime Minister Boris Johnson warned of a "tidal wave" of the highly transmissible variant on its way as he issued an urgent televised address.
It was earlier hinted that the committee would advise the government on allowing additional shots for the vulnerable population apart from vaccination for adolescents and kids.
The vaccines studied were AstraZeneca, Pfizer-BioNTech, Novavax, Janssen, Moderna, Valneva, and Curevac.
Tests showed the omicron variant had infected at least five people in the New York City metropolitan area, plus a man from Minnesota who had attended an anime convention in Manhattan in late November.
The issue of vaccinating health and frontline workers has come foreword after the new variant of Covid-19 'Omicron' is making headlines.
Experts are concerned that the pattern of mutations detected on the Omicron variant will mean that the protection generated by the current generation of vaccines may take a partial hit.
Two other booster shots with vaccines made by Pfizer/Biontech and Moderna have already been approved for use in the EU.
Studies have also shown that the existing Covid vaccines, though potent, are far from being perfect and while they reduce the risks of hospitalisation and severe disease, they do not eliminate them.